Systemic administration of radionuclides in neuroblastoma as planned radiotherapeutic interventionLASHFORD, L. S; CLARKE, J; KEMSHEAD, J. T et al.Medical and pediatric oncology. 1990, Vol 18, Num 1, pp 30-36, issn 0098-1532, 7 p.Article

Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C)LASHFORD, L. S; HANCOCK, J. P; KEMSHEAD, J. T et al.International journal of cancer. 1991, Vol 47, Num 1, pp 105-109, issn 0020-7136, 5 p.Article

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years oldKILTIE, A. E; LASHFORD, L. S; GATTAMANENI, H. R et al.Medical and pediatric oncology. 1997, Vol 28, Num 5, pp 348-354, issn 0098-1532Article

Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyLASHFORD, L. S; THIESSE, P; DUGAN, M et al.Journal of clinical oncology. 2002, Vol 20, Num 24, pp 4684-4691, issn 0732-183X, 8 p.Article

Development of synthetic promoters for radiation-mediated gene therapyMARPLES, B; SCOTT, S. D; HENDRY, J. H et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 6, pp 511-517, issn 0969-7128Article

Diagnosis and therapy of neuroectodermally associated tumours using targeted radiationKEMSHEAD, J. T; LASHFORD, L. S; JONES, D. H et al.Developmental neuroscience. 1987, Vol 9, Num 2, pp 69-83, issn 0378-5866Article

The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrowTURNER, S. D; RAFFERTY, J. A; FAIRBAIRN, L. J et al.Leukemia. 2000, Vol 14, Num 10, pp 1796-1802, issn 0887-6924Article

Chemoprotection of normal tissues by transfer of drug resistance genesRAFFERTY, J. A; HICKSON, I; CHINNASAMY, N et al.Cancer metastasis reviews. 1996, Vol 15, Num 3, pp 365-383, issn 0167-7659Article

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastomaLASHFORD, L. S; MOYES, J; OTT, R et al.European journal of nuclear medicine. 1988, Vol 13, Num 11, pp 574-577, issn 0340-6997Article

A radiation-controlled molecular switch for use in gene therapy of cancerSCOTT, S. D; MARPLES, B; HENDRY, J. H et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 13, pp 1121-1125, issn 0969-7128Article

Leptomeningeal melanoma in childhoodMAKIN, G. W. J; EDEN, O. B; LASHFORD, L. S et al.Cancer. 1999, Vol 86, Num 5, pp 878-886, issn 0008-543XArticle

Chemoprotective gene transfer I : Transduction of human haemopoietic progenitors with O⁶-benzylguanine-resistant O⁶-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O⁶-alkylating agents in vitroHICKSON, I; FAIRBAIRN, L. J; CHINNASAMY, N et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 6, pp 835-841, issn 0969-7128Article

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma : a United Kingdom children's cancer study group invertigationLASHFORD, L. S; LEWIS, I. J; FIELDING, S. L et al.Journal of clinical oncology. 1992, Vol 10, Num 12, pp 1889-1896, issn 0732-183XArticle

Ifosfamide/etoposide alternating with high-dose methotrexate : evaluation of a chemotherapy regimen for poor-risk osteosarcomaMICHELAGNOLI, M. P; LEWIS, I. J; GATTAMANENI, H. R et al.British journal of cancer. 1999, Vol 79, Num 7-8, pp 1174-1178, issn 0007-0920Article

Chemoprotective gene transfer II : Multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O⁶-alkylguanine-DNA alkyltransferaseCHINNASAMY, N; RAFFERTY, J. A; HICKSON, I et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 6, pp 842-847, issn 0969-7128Article

Dosimetry of intrathecal iodine¹³¹ monoclonal antibody in cases of neoplastic meningitisRICHARDSON, R. B; KEMSHEAD, J. T; DAVIES, A. G et al.European journal of nuclear medicine. 1990, Vol 17, Num 1-2, pp 42-48, issn 0340-6997Article

Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assayTURNER, S. D; WIJNHOVEN, S. W. P; TINWELL, H et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2001, Vol 493, Num 1-2, pp 139-147, issn 1383-5718Article

The expression of full length Gp91-Phox protein is associated with reduced amphotropic retroviral productionBELLANTUONO, I; LASHFORD, L. S; RAFFERTY, J. A et al.Haematologica (Roma). 2000, Vol 85, Num 5, pp 451-457, issn 0390-6078Article

Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells : implications for chemoprotective gene therapyCHINNASAMY, N; RAFFERTY, J. A; LASHFORD, L. S et al.Leukemia. 1999, Vol 13, Num 11, pp 1776-1783, issn 0887-6924Conference Paper

Intrathecal administration of I radiolabelled monoclonal antibody as a treatment for neoplastic meningitisMOSELEY, R. P; DAVIES, A. G; KEMSHEAD, J. T et al.British journal of cancer. 1990, Vol 62, Num 4, pp 637-642, issn 0007-0920, 6 p.Article

Isolated biotin-resistant 3-methylcrotonyl CoA carboxylase deficiency presenting with life-threatening hypoglycaemiaBARTLETT, K; BENNETT, M. J; HILL, R. P et al.Journal of inherited metabolic disease. 1984, Vol 7, Num 4, issn 0141-8955, 182Article

A novel dual function retrovirus expressing multidrug resistance 1 and O⁶-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agentsJELINEK, J; RAFFERTY, J. A; BAUM, C et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 8, pp 1489-1493, issn 0969-7128Article

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplantsWYNN, R. F; CROSS, M. A; HATTON, C et al.Lancet (British edition). 1998, Vol 351, Num 9097, pp 178-181, issn 0140-6736Article

Pediatric oncology and hematology in Manchester, EnglandEDEN, O. B; BIRCH, J; WILL, A et al.Pediatric hematology and oncology. 1997, Vol 14, Num 3, pp 191-197, issn 0888-0018Article

Uptake of α-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitroSTEWART, K; BROWN, O. A; MORELLI, A. E et al.Gene therapy (Basingstoke). 1997, Vol 4, Num 1, pp 63-75, issn 0969-7128Article